331 related articles for article (PubMed ID: 9038722)
1. Binding of human and rat CD59 to the terminal complement complexes.
Lehto T; Morgan BP; Meri S
Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
[TBL] [Abstract][Full Text] [Related]
2. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
3. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
5. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.
Lockert DH; Kaufman KM; Chang CP; Hüsler T; Sodetz JM; Sims PJ
J Biol Chem; 1995 Aug; 270(34):19723-8. PubMed ID: 7544344
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
Huang Y; Fedarovich A; Tomlinson S; Davies C
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):714-21. PubMed ID: 17505110
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for membrane attack complex inhibition by CD59.
Couves EC; Gardner S; Voisin TB; Bickel JK; Stansfeld PJ; Tate EW; Bubeck D
Nat Commun; 2023 Feb; 14(1):890. PubMed ID: 36797260
[TBL] [Abstract][Full Text] [Related]
8. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
Sawant-Mane S; Piddlesden SJ; Morgan BP; Holers VM; Koski CL
J Neuroimmunol; 1996 Sep; 69(1-2):63-71. PubMed ID: 8823377
[TBL] [Abstract][Full Text] [Related]
9. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
[TBL] [Abstract][Full Text] [Related]
10. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
11. Studies of the association of the eighth and ninth components of human complement within the membrane-bound cytolytic complex.
Monahan JB; Stewart JL; Sodetz JM
J Biol Chem; 1983 Apr; 258(8):5056-62. PubMed ID: 6833292
[TBL] [Abstract][Full Text] [Related]
12. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
[TBL] [Abstract][Full Text] [Related]
13. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
14. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
Bhakdi S; Tranum-Jensen J
J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
[TBL] [Abstract][Full Text] [Related]
15. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
Tschopp J; Chonn A; Hertig S; French LE
J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
[TBL] [Abstract][Full Text] [Related]
16. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
17. High-resolution structures of bacterially expressed soluble human CD59.
Leath KJ; Johnson S; Roversi P; Hughes TR; Smith RA; Mackenzie L; Morgan BP; Lea SM
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Aug; 63(Pt 8):648-52. PubMed ID: 17671359
[TBL] [Abstract][Full Text] [Related]
18. Identity of a peptide domain of human C9 that is bound by the cell-surface complement inhibitor, CD59.
Chang CP; Hüsler T; Zhao J; Wiedmer T; Sims PJ
J Biol Chem; 1994 Oct; 269(42):26424-30. PubMed ID: 7523406
[TBL] [Abstract][Full Text] [Related]
19. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
Zalman LS; Müller-Eberhard H
Mol Immunol; 1994 Mar; 31(4):301-5. PubMed ID: 8139583
[TBL] [Abstract][Full Text] [Related]
20. Single-molecule kinetics of pore assembly by the membrane attack complex.
Parsons ES; Stanley GJ; Pyne ALB; Hodel AW; Nievergelt AP; Menny A; Yon AR; Rowley A; Richter RP; Fantner GE; Bubeck D; Hoogenboom BW
Nat Commun; 2019 May; 10(1):2066. PubMed ID: 31061395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
